Systematic review with meta-analysis: the effectiveness of either ustekinumab or vedolizumab in patients with Crohn’s disease refractory to anti-tumour necrosis…
Systemic Inflammation in Preclinical Ulcerative Colitis Daniel Bergemalm et al. BACKGROUND & AIMS: Preclinical ulcerative colitis is poorly defined. We…
AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review Sanjay K.…
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease Daniel C. Baumgart et al. Crohn’s disease and ulcerative colitis, together…
The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis Jean-Frédéric LeBlanc et al. Abstract The gut microbiome has been…
Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients Eelco C. Brand et al.…
The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable Anita Afzali et al. Abstract In the USA, an…
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations Stephan Miehlke et al.…
The Global Incidence of Faecal Microbiota Transplantation-related Adverse Events From 2000 to 2020 Cicilia Marcella et al. Abstract Background: Faecal microbiota…
The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis…
The intestinal barrier, an arbitrator turned provocateur in IBD Mehandru S, and Colombel JF Key studies published in 2020 demonstrate…
The Microbiota-Gut-Brain Axis: From Motility to Mood Kara G. Margolis et al. Abstract The gut-brain axis plays an important role…
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease. Angela Ancona et al. Introduction Gut microbiota (GM) has…
Infezione da Clostridium difficile e malattie infiammatorie croniche intestinali LUCIO CAPURSO1, MAURIZIO KOCH2 1Primario Emerito Gastroenterologia, Ospedale San Filippo Neri, Roma; 2Senior Director,…
Combination Therapy with Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy-a Post-hoc analysis.Colombel JF, Adedokun OJ, Gasink C, Gao…
Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.Miehlke S, Aust D, Mihaly E,…
Methotrexate is not superior to placebo in maintaining steroid-free response or remission in ulcerative colitis.Herfarth H, Barnes EL, Valentine JF,…
Systematic review: safety of mesalazine in ulcerative colitis.Sehgal P, Colombel JF, Aboubakr A, Narula N. Aliment Pharmacol Ther. 2018…
Review article: novel oral‐targeted therapies in inflammatory bowel disease.J. R. White,F. Phillips,T. Monaghan,W. Fateen,S. Samuel,S. Ghosh,G. W. Mora. APT First…
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases. Mitrev N, Vande…
Endoscopic morphologic features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement.Sugimoto S, Naganuma M, Iwao Y, Matsuoka…
Impact of Mucosal Inflammation on Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis.Flores BM,…
Changes in medical management and colectomy rates: a population-based cohort study on the epidemiology and natural history of ulcerative colitis…
Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.Leong RW, Ooi M, Corte C, Yau Y, Kermeen…